Aileron Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Rein Therapeutics

15/08/2022 22:25

* Aileron Therapeutics Inc  ALRN.OQ  reported a quarterly
adjusted
loss of 9 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 9 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aileron Therapeutics Inc's reported EPS for the quarter
was a
loss of 9 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.6%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Aileron Therapeutics Inc shares had fallen by 18.5% this
quarter and lost 62.3% so far this year.
    * The company reported a quarterly loss of $7.99 million.
    * Wall Street's median 12-month price target for Aileron
Therapeutics Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:25 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.09          -0.09          Met
 Mar. 31 2022      -0.08          -0.09          Missed
 Dec. 31 2021      -0.08          -0.08          Met
 Sep. 30 2021      -0.07          -0.07          Met